Equities researchers at Zacks Research lifted their FY2025 earnings per share estimates for shares of Bruker in a research ...

Bruker Co. (NASDAQ:BRKR – Get Free Report) has received a consensus rating of “Moderate Buy” from the eleven analysts that are presently covering the company, Marketbeat Ratings reports. Five research ...

Bruker’s BRKR strong growth reflects its fundamental commitment to innovate high-value solutions and ongoing portfolio ...

Wrapping up Q4 earnings, we look at the numbers and key takeaways for the research tools & consumables stocks, including ...

Key Players: Major companies operating in the molecular spectroscopy market are Thermo Fisher Scientific, Inc, Merck KGaA, PerkinElmer Inc., Agilent Technologies, Inc, Bruker, Horiba, Ltd, Shimadzu ...

Bruker Corporation BRKR recently launched the new X4 POSEIDON, a high-performance 3D X-ray microscope (XRM) using ...

We recently compiled a list of the 7 Best Medical Technology Stocks To Buy According To Analysts. In this article, we are ...

Headlines,Bruker Corporation,(NASDAQ:BRKR),specializes in scientific instruments and diagnostic solutions.,The stock experienced a one-month return of -9.12% and a year-over-year decrease of ...

The London Company, an investment management company, released “The London Company Large Cap Strategy” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here. U.S. equities ...

In its fourth quarter 2024 investor letter, The London Company SMID Cap Strategy emphasized stocks such as Bruker Corporation (NASDAQ:BRKR). Bruker Corporation (NASDAQ:BRKR) focuses on developing ...

Bruker Corporation (Nasdaq: BRKR) announced today that it will unveil significant advancements in spatial biology at the 2025 ...

Bruker Spatial Biology will announce the following four innovations that underscore Bruker’s leading commitment to advancing spatial biology with pioneering, best-in-class platforms: The Whole ...